Home › NDC Lookup › Ingredients › Salicylic Acid › 68479-0141-02
RETINOL CLEARING Salicylic Acid 2 mg/100mL Oil — NDC 68479-0141-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

RETINOL CLEARING Salicylic Acid 2 mg/100mL Oil — NDC 68479-141-02 (Billing 68479-0141-02)

by Dermalogica, LLC. · 1 BOTTLE in 1 CARTON / 30 mL in 1 BOTTLE

This is a package of RETINOL CLEARING Salicylic Acid 2 mg/100mL Oil from Dermalogica, LLC., marketed since Aug 2019 and currently FDA-listed. It is this product's only package size.

NDC 68479-0141-02
🏷️ FDA NDC (as labeled) 68479-141-02 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 68479-141-02 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
68479 labeler · 141 product · 02 package
Package marketed since
Aug 27, 2019
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 6847914102 1
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 68479-141-02
Product NDC 68479-141
11-digit billing NDC 68479014102
UNII O414PZ4LPZ
Application # M006
SPL Set ID 4c20d87c-f3cf-4a40-acec-b0a8bfb9b29c
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-08-27
Route TOPICAL
Dosage form OIL
Substance SALICYLIC ACID
Why two NDCs? The FDA registers this code as 68479-141-02 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 68479-0141-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

This is an over-the-counter topical oil containing salicylic acid, marketed as an OTC monograph drug under FDA's established rules for this product category. Salicylic acid is commonly used in skincare products to help exfoliate and clear the skin. This oil formulation is typically applied to the skin to address concerns related to acne and similar conditions where exfoliation is desired.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
68479-0141-02 You're viewing this Main listing 1 BOTTLE in 1 CARTON / 30 mL in 1 BOTTLE 2019-08-27 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Proactiv Clean Acne Clearing Hydrator 2 mg/100mL 11410-0458-00 Alchemee, 1 tube — — FDA listed —
Retinoid Clearing 2 mg/100mL 68479-0041-02 Dermalogica, 1 bottle — — FDA listed —
Good Molecule Maximum Strenght Acne 2 mg/100mL 68577-0231-01 COSMAX 1 tube — — Discontinued —
Retinol Clearing 2 mg/100mLthis 68479-0141-02 Dermalogica, 1 bottle — — FDA listed —
Ouai Anti-Dandruff 2 mg/100mL 84126-0905-30 The 300 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
Aug 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII BO24ID7E9U
    A synthetic fragrance compound used as a flavor or scent agent in medicines to mask unpleasant tastes or odors and improve patient acceptance of the medication.
  • UNII 4V59G5UW9X
    Argan oil is a plant-derived oil from argan tree kernels. It's used in medicines as an emollient and skin-conditioning agent to help soften and moisturize the product's texture.
  • UNII Q86RQ0D402
    A synthetic compound derived from avocado oil, used as an emollient and skin-conditioning agent in topical formulations to help soften and smooth the product texture while improving spreadability on skin.
  • UNII 1P9D0Z171K
    BHT is a synthetic antioxidant that prevents fats and oils in medicines from breaking down and becoming rancid. It helps keep the product stable and effective during storage.
  • UNII 114P5I43UJ
    A hydrocarbon oil derived from petroleum, containing 13 to 15 carbon atoms per molecule. It serves as a lubricant and glidant in tablets and capsules to reduce friction during manufacturing and improve powder flow.
  • UNII 936JST6JCN
    Cetyl alcohol is a waxy, fatty substance derived from plant or animal sources. It acts as an emulsifier and thickener in medicines, helping blend oil and water components and giving products a smooth, creamy texture.
  • UNII 1E5KJY107T
    A liquid mixture derived from coconut oil, coconut alkanes serve as a solvent and lubricant in medicines. They help dissolve active ingredients and reduce friction during manufacturing and tablet compression.
  • UNII 8D9H4QU99H
    A synthetic fatty acid ester derived from coconut oil, used as an emulsifier and solubilizer to help mix oil and water-based ingredients and improve how the body absorbs certain drugs.
  • UNII O05EC62663
    A natural oil derived from glycerin and oleic acid. It acts as a lubricant and emollient in medicines, helping ingredients mix smoothly and improving how the product flows during manufacturing and application.
  • UNII 9XP4LC555B
    A fragrance compound derived from natural plant sources or made synthetically. It's added to medicines as a flavoring agent to mask bitter tastes and improve how the medicine smells and tastes.
  • UNII LYR06W430J
    A synthetic surfactant derived from coconut oil and amino acids. It works as a cleansing agent and emulsifier in topical medicines, helping to mix oil and water-based ingredients and improve skin penetration.
  • UNII 724GKU717M
    Jojoba oil is a natural liquid wax extracted from jojoba plant seeds. It's used in medicines as an emollient and lubricant to soften and smooth the product, and sometimes as a carrier or penetration enhancer.
  • UNII C9H2L21V7U
    A fat derived from coconut or palm oil containing shorter fatty acid chains. It serves as a solvent and carrier to help dissolve or suspend active ingredients, improving absorption and stability in liquid formulations.
  • UNII G37UFG162O
    A synthetic compound that acts as a preservative and antioxidant in medications. It helps prevent bacterial and fungal growth while protecting the medicine from degradation caused by oxygen exposure.
  • UNII 1II18XLS1L
    A synthetic oily liquid made from propylene glycol and stearyl alcohol. It acts as an emulsifier and solubilizer to help mix oil and water-based ingredients together in the medicine.
  • UNII 32JK994WMC
    Retinyl propionate is a form of vitamin A ester used in medications and supplements. It acts as an active ingredient rather than a typical inactive excipient, providing vitamin A activity in the formulation.
  • UNII CR7307M3QZ
    Rosa canina fruit oil is a natural oil extracted from rosehip fruit. It's used in medicines as an emollient and skin-conditioning agent to help soften and smooth the product's texture or skin contact surface.
  • UNII 37W4O0O6E6
    Sclareolide is a fragrant compound derived from natural plant sources. It functions as a flavoring agent to improve the taste and aroma of the medication.
  • UNII E2Q02N1ZC7
    A fragrant oil extracted from tanacetum annuum flower tops, used as a flavoring and scent agent to improve the taste and aroma of medicines.
  • UNII R0ZB2556P8
    Tocopherol is a form of vitamin E derived from plant oils. It acts as an antioxidant in medicines to prevent oils and fats from breaking down and spoiling during storage.

20 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesCoconut Alkanes, PPG-15 Stearyl Ether, Rosa Canina Fruit Oil, Simmondsia Chinensis (Jojoba) Seed Oil, C13-15 Alkane, Coco-Caprylate/Caprate, Argania Spinosa Kernel Oil, Caprylic/ Capric Triglyceride, Isopropyl Lauroyl Sarcosinate, Retinyl Propionate, Butyl Avocadate, Phenylethyl Resorcinol, Tanacetum Annuum Flower Oil, Sclareolide, Triolein, Cetyl Alcohol, Hydroxymethoxyphenyl Decanone, Tocopherol, BHT, Alpha-Isomethyl Ionone.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerDermalogica, LLC.
FDA applicationM006 (OTC MONOGRAPH DRUG)
Labeler code68479
First marketedAug 2019
Product typeHuman Otc Drug
Portfolio17 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 6 words ▾

Indications For the treatment of acne

⏱️ Dosage and Administration 86 words ▾

Directions When using this product Clean the skin thoroughly before applying this product. Skin irritation and dryness are more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Press button and release to fill dropper. At night, after cleansing, gently press button to dispense 6-10 drops into hands. Smooth over face and neck.

If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

⚠️ Warnings 74 words ▾

Warnings For external use only This product contains Retinol, a form of Vitamin A. If pregnant or breastfeeding, consult a physician prior to use. Avoid contact with eyes. If contact with eyes occurs, flush thoroughly with water. Use sunscreen and limit sun exposure when using this product. Do not use with other products containing Retinol. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 5 words ▾

Active Ingredient Salicylic Acid (2.0%)

🧪 Inactive Ingredients 49 words ▾

Inactive Ingredients Coconut Alkanes, PPG-15 Stearyl Ether, Rosa Canina Fruit Oil, Simmondsia Chinensis (Jojoba) Seed Oil, C13-15 Alkane, Coco-Caprylate/Caprate, Argania Spinosa Kernel Oil, Caprylic/ Capric Triglyceride, Isopropyl Lauroyl Sarcosinate, Retinyl Propionate, Butyl Avocadate, Phenylethyl Resorcinol, Tanacetum Annuum Flower Oil, Sclareolide, Triolein, Cetyl Alcohol, Hydroxymethoxyphenyl Decanone, Tocopherol, BHT, Alpha-Isomethyl Ionone.

🎯 Purpose 3 words ▾

Purpose Acne treatment

📄 When Using This Product 85 words ▾

When using this product Clean the skin thoroughly before applying this product. Skin irritation and dryness are more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Press button and release to fill dropper. At night, after cleansing, gently press button to dispense 6-10 drops into hands. Smooth over face and neck.

If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 10 words ▾

Questions or comments Call toll free 1-800-831-5150 in the US.

📄 Package Label / Principal Display Panel 49 words ▾

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton BREAKOUTS + SKIN AGING two problems. one solution. retinol clearing oil clears skin overnight Active Clearing 1 US FL OZ / 30 mL ℮ dermalogica professional-grade skin care by The International Dermal Institute Principal Display Panel - 30 mL Bottle Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Salicylic Acid (matched by generic name) — the program that covers self-administered drugs. 2 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Salicylic Acid. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$11.2K
Claims incl. refills
43
Beneficiaries
35
Spend / beneficiary
$319.01
Spend / claim
$259.66
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for RETINOL CLEARING (this brand).

Top reported reactions

Vomiting216
Pruritus205
Weight Decreased188
Condition Aggravated184
Urticaria184
Weight Increased183
Hypertension181

Reporter sex

1,852 reports
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 243 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Dermalogica, LLC.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Dermalogica, LLC. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.